Acinetobacter infection – an emerging threat to human health
暂无分享,去创建一个
[1] J. Heritage,et al. Description of Leeds Acinetobacter Medium, a new selective and differential medium for isolation of clinically important Acinetobacter spp., and comparison with Herellea agar and Holton's agar , 1994, Journal of clinical microbiology.
[2] P. Higgins,et al. Global spread of carbapenem-resistant Acinetobacter baumannii. , 2010, The Journal of antimicrobial chemotherapy.
[3] P. Janssen,et al. Discrimination of Acinetobacter genomic species by AFLP fingerprinting. , 1997, International journal of systematic bacteriology.
[4] K. Petersen,et al. Acinetobacter baumannii skin and soft-tissue infection associated with war trauma. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] S. D. Henriksen. Moraxella, Acinetobacter, and the Mimeae. , 1973, Bacteriological reviews.
[6] S. Brisse,et al. Molecular Epidemiology of Multidrug-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Naples, Italy, Shows the Emergence of a Novel Epidemic Clone , 2010, Journal of Clinical Microbiology.
[7] H. Seifert,et al. Nosocomial Bacteremia due to Acinetobacter baumannii: Clinical Features, Epidemiology, and Predictors of Mortality , 1995, Medicine.
[8] M. Luczak,et al. Biofilm production by clinical strains of Acinetobacter baumannii isolated from patients hospitalized in two tertiary care hospitals. , 2008, FEMS immunology and medical microbiology.
[9] J. Garnacho-Montero,et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] Erko Stackebrandt,et al. Taxonomic Note: A Place for DNA-DNA Reassociation and 16S rRNA Sequence Analysis in the Present Species Definition in Bacteriology , 1994 .
[11] K. Davis,et al. Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers , 2005, Emerging infectious diseases.
[12] M. Vaneechoutte,et al. Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. , 1998, Systematic and applied microbiology.
[13] I. Goic-Barisic,et al. Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase. , 2011, The Journal of hospital infection.
[14] M. Adams,et al. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. , 2010, The Journal of antimicrobial chemotherapy.
[15] P. Visca,et al. Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates. , 2011, Research in microbiology.
[16] P. Higgins,et al. gyrB Multiplex PCR To Differentiate between Acinetobacter calcoaceticus and Acinetobacter Genomic Species 3 , 2010, Journal of Clinical Microbiology.
[17] Jonathan R Edwards,et al. Overview of nosocomial infections caused by gram-negative bacilli. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] R. Wenzel,et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] M. Gillis,et al. Taxonomy of Moraxellaceae fam. nov., a New Bacterial Family To Accommodate the Genera Moraxella, Acinetobacter, and Psychrobacter and Related Organisms , 1991 .
[20] L. Dijkshoorn,et al. Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. , 2006, Research in microbiology.
[21] L. Dijkshoorn,et al. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.
[22] Harald Seifert,et al. Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.
[23] R. Hall,et al. Evolution of AbaR-type genomic resistance islands in multiply antibiotic-resistant Acinetobacter baumannii. , 2010, The Journal of antimicrobial chemotherapy.
[24] L. Peixe,et al. Understanding the dynamics of imipenem-resistant Acinetobacter baumannii lineages within Portugal. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[25] A. Carattoli,et al. Distribution of Intrinsic Plasmid Replicase Genes and Their Association with Carbapenem-Hydrolyzing Class D β-Lactamase Genes in European Clinical Isolates of Acinetobacter baumannii , 2011, Antimicrobial Agents and Chemotherapy.
[26] P. Visca,et al. Identification of Variable-Number Tandem-Repeat (VNTR) Sequences in Acinetobacter baumannii and Interlaboratory Validation of an Optimized Multiple-Locus VNTR Analysis Typing Scheme , 2010, Journal of Clinical Microbiology.
[27] D. Paterson,et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. , 2009, The Lancet. Infectious diseases.
[28] Chong-Jen Yu,et al. Severe community-acquired pneumonia due to Acinetobacter baumannii. , 2001, Chest.
[29] J. Heritage,et al. Survival of Acinetobacter baumannii on Dry Surfaces: Comparison of Outbreak and Sporadic Isolates , 1998, Journal of Clinical Microbiology.
[30] R. Gaynes,et al. NATIONAL NOSOCOMIAL INFECTIONS SURVEILLANCE S. OVERVIEW OF NOSOCOMIAL INFECTIONS CAUSED BY GRAM-NEGATIVE BACILLI , 2005 .
[31] R. Schmitt,et al. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. , 2007, The Journal of hospital infection.
[32] S. Valdezate,et al. Clonal Diversity of Nosocomial Epidemic Acinetobacter baumannii Strains Isolated in Spain , 2010, Journal of Clinical Microbiology.
[33] H. Seifert,et al. Molecular Epidemiology of Acinetobacter Species , 2008 .
[34] Qing Yang,et al. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. , 2010, The Journal of antimicrobial chemotherapy.
[35] P. Nordmann,et al. Worldwide Dissemination of the blaOXA-23 Carbapenemase Gene of Acinetobacter baumannii1 , 2010, Emerging infectious diseases.
[36] L. Dijkshoorn,et al. The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool , 2010, PloS one.
[37] J. Patel,et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] M. Kaufmann,et al. Identification of Acinetobacter baumannii by Detection of the blaOXA-51-like Carbapenemase Gene Intrinsic to This Species , 2006, Journal of Clinical Microbiology.
[39] M. Falagas,et al. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue , 2007, Critical care.
[40] P. Higgins,et al. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[41] Yee-Chun Chen,et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] P. Higgins,et al. Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.